Cargando…
Nutraceuticals : efficacy, safety and toxicity /
Nutraceuticals: Efficacy, Safety and Toxicity brings together all current knowledge regarding nutraceuticals and their potential toxic effects as written by the scientists at the forefront of their study. Users will find an introduction to nutraceuticals, herbal medicines, ayurvedic medicines, prebi...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
Academic Press,
[2016]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | KNOVEL_ocn936379312 | ||
| 003 | OCoLC | ||
| 005 | 20231027140348.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 160202t20162016enka ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d YDXCP |d IDEBK |d EBLCP |d N$T |d OPELS |d CDX |d OCLCF |d KNOVL |d COO |d OCLCQ |d U3W |d MERUC |d D6H |d CEF |d RRP |d OCLCQ |d AU@ |d UKMGB |d OCLCQ |d LQU |d OCLCQ |d VLY |d S2H |d OCLCO |d REDDC |d LVT |d OCLCO |d OCLCQ |d OCLCO | ||
| 015 | |a GBB6I9531 |2 bnb | ||
| 015 | |a GBB611177 |2 bnb | ||
| 016 | 7 | |a 017993084 |2 Uk | |
| 016 | 7 | |a 017711510 |2 Uk | |
| 019 | |a 945766669 |a 1105172596 |a 1105567369 |a 1162020349 |a 1229062321 |a 1229134224 |a 1229509987 |a 1232036129 |a 1232398661 |a 1259586497 |a 1357348412 | ||
| 020 | |a 9780128021651 |q (electronic bk.) | ||
| 020 | |a 0128021659 |q (electronic bk.) | ||
| 020 | |a 0128021470 | ||
| 020 | |a 9780128021477 | ||
| 020 | |z 9780128021477 | ||
| 029 | 1 | |a AU@ |b 000057103947 | |
| 029 | 1 | |a CHBIS |b 010796179 | |
| 029 | 1 | |a CHVBK |b 40393981X | |
| 029 | 1 | |a GBVCP |b 856001708 | |
| 029 | 1 | |a GBVCP |b 871530368 | |
| 029 | 1 | |a UKMGB |b 017711510 | |
| 029 | 1 | |a UKMGB |b 017993084 | |
| 035 | |a (OCoLC)936379312 |z (OCoLC)945766669 |z (OCoLC)1105172596 |z (OCoLC)1105567369 |z (OCoLC)1162020349 |z (OCoLC)1229062321 |z (OCoLC)1229134224 |z (OCoLC)1229509987 |z (OCoLC)1232036129 |z (OCoLC)1232398661 |z (OCoLC)1259586497 |z (OCoLC)1357348412 | ||
| 037 | |a 9780128021651 |b Ingram Content Group | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a QP144.F85 | |
| 072 | 7 | |a HEA |x 010000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 012000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 020000 |2 bisacsh | |
| 072 | 7 | |a MED |x 076000 |2 bisacsh | |
| 082 | 0 | 4 | |a 613.2 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Nutraceuticals : |b efficacy, safety and toxicity / |c edited by Ramesh C. Gupta. |
| 264 | 1 | |a London : |b Academic Press, |c [2016] | |
| 264 | 4 | |c ©2016 | |
| 300 | |a 1 online resource : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Online resource; title from PDF title page (Ebsco, viewed February 17, 2016). | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a Nutraceuticals: Efficacy, Safety and Toxicity brings together all current knowledge regarding nutraceuticals and their potential toxic effects as written by the scientists at the forefront of their study. Users will find an introduction to nutraceuticals, herbal medicines, ayurvedic medicines, prebiotics, probiotics, and adaptogens, along with their use and specific applications. This essential reference then discusses the mechanism of action for the judicious use of these nutraceuticals and the best tools for their evaluation before detailing the safety and toxicity of nutraceuticals and their interactions with other therapeutic drugs. Finally, and crucially, regulatory aspects from around the world are covered, providing a comprehensive overview of the most effective tools for the evaluation, safety, and toxicity of nutraceuticals, prebiotics, probiotics, and alternative medicines. | ||
| 505 | 0 | |a Front Cover; Nutraceuticals; Copyright Page; Dedication; Contents; List of Contributors; Introduction; Introduction; References; I. Applications of Nutraceuticals in Common Diseases and Disorders; 1 Nutraceuticals in CNS Diseases: Potential Mechanisms of Neuroprotection; Introduction; Polyphenols; Counteracting Oxidative Stress as a Mechanism of Neuroprotection; Direct Antioxidant Action of Quercetin; Potential Role of Hormesis in Neuroprotection; Modulation of the Nrf2-ARE Pathway as a Mechanism of Quercetin Neuroprotection. | |
| 505 | 8 | |a Modulation of Paraoxonase 2 (PON2) as a Potential Novel Mechanism of Quercetin NeuroprotectionParaoxonase 2; Paraoxonase 2 in the Central Nervous System; Gender Differences in Paraoxonase 2 Expression; Modulation of Paraoxonase 2; Modulation of Paraoxonase 2 by Quercetin; The Issue of Metabolites; Concluding Remarks and Future Directions; Acknowledgments; References; 2 Prevention of Neurodegenerative Disorders by Nutraceuticals; Introduction; Nutraceuticals for the Prevention and Amelioration of AD; Nutraceuticals for the Prevention and Amelioration of PD. | |
| 505 | 8 | |a Nutraceuticals for the Prevention and Amelioration of ASDConcluding Remarks and Future Directions; References; 3 Cognitive Effects of Nutraceuticals; Introduction; Biological Basis of Cognition; Overview of Cognition; Cellular Basis of Information Storage; Synaptic Plasticity as a Physical Basis for Memory; Biological Basis of Dementia; Nutraceuticals with Potential Cognitive Enhancing Functions; Ginkgo biloba; Positive Effects; Potential Mechanisms; Negative or Null Effects; Bacopa monnieri; Positive Effects; Potential Mechanisms; Negative or Null Effects; Ginseng; Positive Effects. | |
| 505 | 8 | |a Potential MechanismNegative or Null Effects; Phosphatidylserine; Positive Effects; Potential Mechanisms; Negative or Null Effects; Caffeine; Positive Effects; Potential Mechanisms; Negative or Null Effects; Centella asiatica, Ephedra sinica, and Crocus sativus; Potential Concerns of Cognitive Enhancement; Concluding Remarks and Future Directions; References; 4 Nutraceuticals in Cardiovascular Diseases; Introduction; Cardiac Dysfunction; Features of Cardiac Disease; Hypertension; Coronary Artery Disease (CAD)-Atherosclerosis; Ischemia; Hypertrophy; Oxidative Stress; Vascular Injury. | |
| 505 | 8 | |a Biomarkers of Heart DiseaseTherapeutic Response to Heart Disease; Phytotherapeutic Strategies; Nutraceuticals; Cruciferous Vegetables; Bulbous Plants; Tea; CoQ10; Turmeric; Grape Skin; Fish Oil/Olive Oil; Vegetables; Carnitine; Soy; Concluding Remarks and Future Directions; References; 5 Antiatherosclerotic Efficacy of Nutraceuticals; Introduction; Pathogenesis of Atherosclerosis and Possible Points of Therapeutic Intervention; Role of LDL; Atherosclerotic Plaque Formation; Existing and Emerging Antiatherosclerotic Therapies; Nutraceuticals with Antiatherosclerotic Activity. | |
| 546 | |a English. | ||
| 590 | |a Knovel |b ACADEMIC - Food Science | ||
| 650 | 0 | |a Functional foods. | |
| 650 | 0 | |a Nutrition. | |
| 650 | 2 | |a Nutritional Physiological Phenomena | |
| 650 | 6 | |a Nutraceutiques. | |
| 650 | 6 | |a Nutrition. | |
| 650 | 7 | |a HEALTH & FITNESS |x Healthy Living. |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS |x Holism. |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS |x Reference. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Preventive Medicine. |2 bisacsh | |
| 650 | 7 | |a Functional foods |2 fast | |
| 650 | 7 | |a Nutrition |2 fast | |
| 700 | 1 | |a Gupta, Ramesh C. |q (Ramesh Chandra), |d 1949- |e author, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Nutraceuticals : efficacy, safety and toxicity. |d Amsterdam, [Netherlands] : Academic Press, ©2016 |h xiv, 1021 pages |z 9780128021477 |
| 856 | 4 | 0 | |u https://appknovel.uam.elogim.com/kn/resources/kpNEST0002/toc |z Texto completo |
| 938 | |a Coutts Information Services |b COUT |n 33755799 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4387032 | ||
| 938 | |a EBSCOhost |b EBSC |n 1144200 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis33755799 | ||
| 938 | |a YBP Library Services |b YANK |n 12828831 | ||
| 994 | |a 92 |b IZTAP | ||